Ascending The Portfolio Optimization Maturity Curve

09mar8:00 am9:00 amAscending The Portfolio Optimization Maturity CurveUS PACIFIC TIME ZONE

Event Details

This talk will explore how biopharma companies can ascend the maturity curve from ad hoc to data-driven/robust portfolio optimization. Topics covered will include the pros & cons of various portfolio optimization approaches (and software options), as well as organizational challenges of implementation.

Objectives:

Understand the foundations of PPM/PPO
Appreciate why PPM/PPO is hard
Be aware of key frameworks for PPM/PPO
Be aware of key software tools for PPM/PPO
Understand maturity assessments used for PPM/PPO
As a PM, provide better inputs to the PPM/PPO process

Speakers for this event

Tom Heaps-Nelson

Tom Heaps-Nelson
Senior Program Manager at Neurocrine Biosciences
Tom Heaps-Nelson is a Senior Program Manager in drug development at Neurocrine Biosciences. Previously, Tom was a biopharma management consultant with Skysis LLS, with Scimitar Inc, and as an independent consultant. He is passionate about improving teams, systems, and strategic decision-making.
Tom holds an MS in Chemical Engineering, PhD in Engineering Systems, and MBA from MIT. He is PMP and Smartsheet certified. In his spare time, Tom enjoys hiking, fishing, and playing tennis.
Senior Program Manager at Neurocrine Biosciences